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The fields of tissue engineering, regenerative medicine, and stem cell 
engineering are rapidly growing.  However, these fields must overcome several 
obstacles before they can make a significant impact on treating cellular disorders.  
Two major hurdles that must be addressed are: determining how to control the 
pluripotency of stem cells and developing systems for high-throughput culture of 
stem cells.  The prospect of using a cell source capable of differentiating into cells of 
any tissue in the body (embryonic stem cells) has received enormous interest in 
vii 
recent years.  The pluripotent attribute of embryonic stem cells seems ideal but 
developing methods to drive embryonic stem cells to specific lineages, including the 
hematopoietic lineage, is a complex process dependent on multiple intrinsic and 
extrinsic factors including chemical, cellular, and environmental signaling.  With 
regards to environmental signaling, the use of three-dimensional culture systems 
such as scaffolds and hydrogels, have been utilized in an attempt to drive lineage-
specific differentiation in a synthetic, biomimetic microenvironment.  To determine 
specific environmental factors responsible for hematopoietic differentiation a 
systematic biological and engineering process must be implemented.   
A biodegradable hydrogel composed of the hyaluronic acid, a polysaccharide 
abundant in the bone marrow microenvironment, and the synthetic polymer, 
poly(ethylene glycol) was formulated to  culture mouse embryonic stem cells 
(mESCs).  Photoencapsulation of mESCs did not significantly decrease cellular 
viability or proliferation.  The FACS data was inconclusive however, from gene 
expression studies, it was determined that the hydrogel culture system promoted 
differentiation of mESCs as evidenced by a down-regulation of the gene encoding for 
stem cell maintenance transcription factor, Oct-3/4.  Furthermore, embryoid bodies, 
necessary for in vitro differentiation were observed in the hydrogel systems.  
Although an increase in the gene encoding for the cell surface marker, c-kit was up-
regulated, the surface marker, sca-1 was not up-regulated.  Up-regulation of both c-
kit and sca-1 is necessary for the development of hematopoietic progenitor cells. 
viii 
Results indicate that the differentiation of mESCs into the hematopoietic lineage was 
unsuccessful but differentiation in these hydrogel systems did occur.  Future cell 
marker and gene expression studies are necessary to determine which cell lineage 
the encapsulated mESCs are differentiating into before the effects of incorporating 
other environmental, cellular, and chemical factors can be investigated. 
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Chapter 1: Introduction 
 
The prospect of treating a wide variety of cellular disorders with cell 
replacement therapy is becoming ever more realistic.  For this reason, cellular 
therapeutic research is becoming increasingly popular. However, the field is 
currently limited by the number of donor cell sources.  The future success of cell 
therapy in disease treatment is strongly dependent on the development of a widely 
available donor source.  Due to their pluripotent and self-renewing nature, stem 
cells are an extremely attractive source for cell therapy.  The creation of a high-
throughput culture system capable of driving the differentiation process of stem 
cells is critical for the ultimate clinical success of cellular therapeutics.  
Currently, hematopoietic stem cells (HSCs) are used in cell replacement 
therapies to treat blood disorders such as leukemia, lymphoma, and myeloma.  HSCs 
used in cell therapy are isolated from the bone marrow of a donor or the patient and 
then transplanted into the patient [1].  Limitations to HSC transplantation include a 
lack of efficient methods for both HSC extraction from the bone marrow and in vitro 
expansion of HSCs as well as a scarcity of matching donors [1].  If an “off-the-shelf” 
HSC supply were available, difficulty in both HSC extraction and the location of 
suitable donors would be eliminated.  However, the problem of developing of a high-
throughput in vitro system specific to HSC expansion still remains.  To solve this 
problem, a basic understanding of HSC development and biology must be obtained. 
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It is well known that three-dimensional (3D) cultures enhance cell-cell and 
cell-environment interactions and further mimics the in vivo environment.  Mouse 
embryonic stem cells (mESCs) cultured on tantalum-based scaffolds and poly(L-
lactic acid) (PLLA) - based scaffolds have been shown to increase the efficiency of 
hematopoiesis [2, 3].  Other studies have shown hyaluronic acid (HA) hydrogels 
promote embryonic stem cell proliferation [4].  The next natural step is to direct 
stem cells to differentiate into one specific cell line: the hematopoietic lineage.  We 
proposed to take a systematic biological approach to mimic the bone marrow 
microenvironment cellularly, molecularly, and environmentally.  A combination of a 
biocompatible material with specific niche proteins may enhance hematopoietic 
differentiation of mESCs in a controlled and repeatable manner.  
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Chapter 2: Background 
 
2.1 Embryonic stem cells and hematopoiesis 
 Stem cells (SCs) are an invaluable self-renewing cell population present 
throughout the human body.  In times of severe stress when an organ needs repair, 
SCs specific to an organ are able to replenish the cell population.  Embryonic stem 
cells (ESCs), first isolated in 1981 from the inner cell mass of a murine blastocyst , 
are able to perpetually proliferate in an undifferentiated state and differentiate into 
multiple cell lineages [5].  In an effort to maintain homeostasis, SCs constantly make 
a choice to either self-renew or differentiate [6, 7].  This decision is a result of both 
intrinsic, cellular and extrinsic, microenvironmental factors [6, 7].  Their pluripotent 
attribute makes ESCs an extremely attractive cell source for tissue engineering and 
regenerative medicine applications.  To date, researchers have been able to promote 
differentiation of ESCs into several cell lineages including vascular, neural, hepatic, 
chondrogenic, pancreatic, and osteogenic lineages [8-14].  In recent years, studies 
have emphasized hematopoietic differentiation given the widespread clinical 
applicability of hematopoietic stem cells (HSCs) [3].  
 Hematopoiesis is the development of blood cellular components including 
erythrocytes, granulocytes, and lymphocytes.  The initial location of hematopoiesis 
is the yolk sac in an embryo, specifically in the blood islands [3, 7, 15, 16].  This 
occurs around day 7.5 of gestation [7, 16].  As development progresses, the site of 
hematopoiesis relocates around day 10 of gestation to the aorta-gonad-
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mesenephros and then to the placenta [13].  From day 12 of gestation until birth, 
hematopoiesis occurs in the fetal liver and spleen [13, 7, 16].  Hematopoiesis 
reaches its final destination at birth in the bone marrow [7, 15, 16].   
HSCs and hematopoietic progenitor or precursor cells (HPCs) ultimately give 
rise to blood components [15].  Current in vitro methods of differentiating stem cells 
involve the formation of embryoid bodies (EBs) in suspension culture [17].  These 
ball-like structures physically resemble the embryo in its initial developmental 
stages [18].  More applicable to stem cell differentiation research is the cellular 
composition of EBs.  EBs contain cells which delineate the three germ layers: 
ectoderm, mesoderm, and endoderm [16].  Between day 2.5 and day 4 of EB culture, 
multiple precursor cell types, including HPCs, capable of differentiating into a 
variety of cell lineages develop [7, 19].  The germ layer of interest in HSC research is 
the mesoderm because HPCs along with endothelial, cardiac, skeletal, and adipocyte 
precursors are located here throughout development [16].  Although EBs contain 
the germ layer and cell lineage of interest, a major obstacle in HSC research is the 
development of an effective, high-throughput hematopoietic ex vivo system.  HSCs 
cultured in vitro and implanted have been shown to have a decrease in engrafting 
and self-renewal capabilities [7].  Therefore an in vitro system combining 
hematopoietic chemical and physical stimuli with EB production could be directed 
to yield large-scale supplies of HPCs and HSCs.  In the future, HSC supplies can be 
used in the treatment of blood disorders including anemia, lymphoma, leukemia, 
and myeloma. 
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Although efforts to create a high-throughput system for the generation of 
HSCs have improved with an increased use of 3D and dynamic culture systems, the 
biological effects of the microenvironmental factors on the hematopoietic 
differentiation process has not been studied in depth.  In order to make strides in 
optimizing a high-throughput HSC differentiation culture system, the environmental 
effects on the differentiation process must be examined.  This study investigated the 
genetic and molecular effects on mESCs when cultured in a fabricated bone marrow 
microenvironment. 
2.2 The bone marrow and the stem cell niche 
 
The bone marrow is a soft anatomical structure situated in the bone cavity 
[15].   It houses specialized microenvironments, known as stem cell “niches,” vital to 
Figure 2- 1. The bone marrow HSC niches.  from Yin et. al.. The stem cell niches in bone. Journal of Clinical 
Investigation 116:1195-1201, 2006. 
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stem cell functions [15, 20].  Niches consist of specific extracellular matrices (ECM) 
and supporting cell lines which cooperatively function to control the major stem cell 
operations: self-renewal, quiescence, and differentiation [15, 21].  The bone marrow 
is known to have two HSC niches which manage hematopoiesis: the endosteal or  
osteoblastic niche and the vascular niche [15, 20]. The endosteal niche, classified as 
a quiescent environment, houses “slow-cycling” long-term HSCs responsible for the 
maintenance of the HSC supply or pool [20]. HSC proliferation and differentiation 
occurs in the vascular niche, where “actively-cycling” short-term HSCs supply the 
body with circulating HSCs and HPCs [15, 20]. 
Supporting evidence from immunofluorescent transplantation studies 
tracked transplanted HSCs in mice to their final location in the bone marrow.  
Results showed cells which had not committed to a lineage (Lin – cells) migrated to 
the endosteum of the bone [22].  Lin + cells, or cells with a determined lineage, 
migrated to the central region of the bone marrow [22].  These results lead to the 
hypothesis of the endosteal niche being the more important of the two HSC niches.  
Although the vascular niche sources the body with blood cells, the endosteal niche is 
the supplier of HSCs to the vascular niche.  Without the endosteal niche, a life-time 
continuance of hematopoiesis is not possible [20]. 
2.3 Three-dimensional stem cell culture  
 The goal of a tissue engineering culture system is to mimic the in vivo 
environment of the tissue.  Extensive tissue engineering research has been 
performed using two-dimensional (2D) culture systems; however, the body is three-
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dimensional.  Furthermore, the body and its organ systems are not static but are 
dynamic.  Circulation of nutrients, hormones, oxygen, and carbon dioxide through 
the vascular system introduces fluid flow into tissue microenvironments.  For these 
reasons, 2D culture systems are not indicative of the natural cellular environment 
and therefore tissue engineers have begun to implement 3D and dynamic culture 
systems. 
Recent studies have demonstrated the effective differentiation of embryonic 
stem cells (ESCs) in 3D biomaterials [2-4, 10, 23].  The utilization of biomaterials to 
create 3D cellular environments in the form of scaffolds and hydrogels has become 
increasingly prevalent in stem cell research.  Scaffolds and hydrogels, essentially 
serve as an artificial ECM leading to successful differentiation studies.  With their 
controllable porosity, scaffolds create a cellular environment conducive to nutrient 
flow, matrix construction, cell-matrix, and cell-cell interactions [18].  mESCs 
cultured in scaffolds constructed with fibrin have been shown to differentiate into 
the vascular lineage [10].  PLLA scaffolds and tantalum-based scaffolds have been 
employed in hematopoietic differentiation of mESCs [3].  Moreover, the addition of 
dynamic nutrient flow (i.e. spinner flask cultures) has increased hematopoietic 
differentiation efficiency [2]. 
Studies have also revealed the potential use of hydrogels as biomimetic 
culture systems for proliferation and guided differentiation of human embryonic 
stem cells (hESCs) [4].  Hwang et al. have proven successful guided chondrogenic 
differentiation of mESCs in poly(ethylene-glycol) (PEG) hydrogels in combination 
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with a growth-factor enhanced culture medium [23].  Their most recent undertaking 
involves the actual incorporation of ECM constituents within their PEG-based 
hydrogel; however, this study was performed with primary chondrocytes not ESCs 
[24].  ECM hydrogels have yet to be investigated in hematopoetic differentiation of 
ESCs.   
2.4 HSC-niche interactions 
The “cross-talk” between HSCs and the endosteal niche is essential for 
transmitting the proper molecular signals involved in hematopoiesis [21].  The ECM 
and specialized cells within the niche are thought to communicate with the stem 
cells through cell-cell and cell-matrix interactions which have not been studied in 
detail [20, 21].  The role of the endosteal niche ECM is not characterized in detail but 
key ECM components including fibronectin, collagen type I, and collagen type IV 
have been identified through immunohistochemical staining [25].  A more recent 
study identified the glycosaminoglycan, hyaluronic acid (HA), as another key ECM 
component.  HA is the third main glycosaminoglycan, in terms of quantity,  
generated by the supporting, stromal cells in the bone marrow [22].  HA composes 
approximately 40% of glycosaminoglycans generated by the stromal cells. [22, 26]  
It functions in the suppression of HSC proliferation and differentiation as well as 
HSC lodgement within niches [21, 22].  Physical contact with ECM components in a 
biomimetic microenvironment may trigger differentiation and signal transduction 
pathways associated with hematopoiesis.  
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2.5 Hyaluronic Acid  
 First discovered in the vitreous humor of the eye by Karl Meyer in 1934, HA 
is a linear, high molecular weight, negatively charged, and acidic glycosaminoglycan 
composed of two repeat units:  D-glucaronic acid β-1 and 3-N-acetylglucosamine-β-
1,4 [27-29].  Naturally occurring HA has a molecular weight ranging from 105 – 107 
Daltons and the most common sources of HA for experimental use include the 
umbilical cord, rooster comb, joint fluids, and streptococci [27-29].  Studies done by 
Scott et al. in 1989 revealed the secondary structure of HA to be helical in nature 
with hydrogen bonds joining the linear polymer chains together [30].  The presence 
of hydrogen bonds allows for the polymer to easily interact with water, creating an 
expanded, coiled structure with a large hydrodynamic radius (20 nm) and high 
viscosity [28, 29].  These structural properties make HA an ideal polymer 
distributed throughout the body’s ECM for lubrication, space-filling, and load-
bearing functions [28]; however, HA also has key roles in the body’s molecular 
interactions. 
2.6 The role of hyaluronic acid in the bone marrow 
As previously stated, HA is a key component of the bone marrow ECM and 
the HSC niche [21, 22, 27].  Studies have reported the importance of HA in a number 
of cellular functions including tissue repair, cell migration, cell proliferation, and 
most importantly cell differentiation [27, 31].  Through its interactions with 
hyaladherins (HA binding proteins) including aggrecan and link proteins, HA 
imparts structural integrity on the bone marrow microenvironment and helps to 
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contain HSCs within the marrow [27, 28].  It also participates in receptor-ligand 
interactions primarily through the cell surface receptor, CD44H (CD44, 
hematopoietic) leading to activation of intracellular signaling cascades [28, 32-35].  
About 50% of total GAG synthesis in the bone marrow is a result of HA synthesis by 
supporting/stromal cells as well as the sinusoidal endothelium of the vascular niche 
and cells on the endosteal surface [26, 36].  The polymer is also synthesized by 
hematopoietic progenitor cells (HPCs), specifically Lin-Sca+Kit+ HPCs [22].  Given the 
presence of HA in the HSC niche (i.e. the endosteal niche) and the production of HA 
by hematopoietic stem cells, the introduction of HA in an artificial, biomimetic 
microenvironment may lead to differentiation of mESCs into the hematopoietic 
lineage. 
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Chapter 3: Materials and Methods 
 
3.1. Hydrogel synthesis and characterization 
3.1.1 Methacrylation of Hyaluronic Acid   
Methacrylated HA was synthesized according to a protocol from Leach et. al. 
[37].  Briefly, 0.5 grams of HA (Sigma-Aldrich, St. Louis, MO) was mixed with 50 
milliliters of a 50:50 dH2O: acetone (Fisher Scientific) solution overnight to allow for 
full dissolution.  3.6 milliliters of triethylamine (Sigma Aldrich, St. Louis, MO) was 
added to the solution and allowed to stir in a closed container for approximately 2 
hours after which, 3.6 milliliters of glycidyl methacrylate (Sigma Aldrich, St. Louis, 
MO) was added and allowed to stir in a closed container in the dark for 24 hours. To 
collect a solid, purified methacrylated HA (MeHA) product two reprecipitations of 
MeHA in acetone (1:20) were conducted.   Following each reprecipitation, the solid 
product was redissolved in 50 milliliters of dH2O overnight.  After the second 
reprecipitation and dissolution, 8 milliliter aliquots of the solution were transferred 
to 15 milliliter centrifuge tubes.  The aliquots were frozen at -20:C for 
approximately 2 hours and then transferred to -80:C for overnight and long-term 
storage.  The frozen aliquots were lyophilized for 3 days to obtain a solid product of 
methacrylated HA.  NMR was performed on freeze-dried samples to verify 
methacrylation. 
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3.1.2 HA hydrogel and HA-PEGDA “co-gel” formation 
Poly(ethylene glycol) diacrylate (PEGDA) (MW 3400, Laysan Bio, Arab, AL) 
and HA “co-gels” as well as pure HA hydrogels were generated similar to methods 
used by Gerecht et. al. [4].  Briefly, PEGDA was dissolved in Phosphate Buffered 
Saline (PBS) at two concentrations (2% and 3% w/v); three concentrations of HA 
were utilized (1%, 1.5%, and 2% w/v).  HA was added to the PEGDA-PBS solution 
and allowed to rotate overnight at room temperature allowing for complete 
dissolution. 0.05% (w/v) of the photoinitiator, Irgacure 2959, was mixed into the 
solution.  100 µl of the polymer solution was pipetted into separate wells of a 96-
well tissue culture plate and placed under a UV lamp (Mercury Spot Lamp, Ted Pella 
Inc., Redding, CA) at an intensity of ~7.5 mW/cm2 until gelation occurred after 
approximately 9 to 10 minutes.  Fully cured hydrogels were then transferred to 
separate wells of a 24-well tissue culture plate and covered with 1 milliliter of PBS.   
3.1.3 Determining degradable HA-PEGDA hydrogels 
To ensure complete degradation and cell release from HA-PEGDA co-gels, 
studies were performed using bovine hyaluronidase (Sigma-Aldrich, St. Louis, MO).  
Following the protocol from Gerecht et. al. [4], hyaluronidase was added to each 
hydrogel sample at varying concentrations (500 U/ml, 1,000 U/ml, 1,500 U/ml, 
2,000 U/ml) and incubated for 24 hours at 37:C on a rotator.   After 24 hours, 
samples were pipetted out and inspected for any solid hydrogel remnants.  Co-gels 
incapable of full degradation were not used in any further studies. 
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3.1.4 Degradation Studies 
Degradation profiles were created by modifying a protocol by Leach et. al. 
[38].  The following hydrogels were formed as described above: 1%HA, 1.5%HA, 
2.0%HA, 1%HA-2%PEGDA, 1.5%HA-2%PEGDA, 1%HA-3%PEGDA, and 1.5%HA-
3%PEGDA.  Each hydrogel was blotted dry with a kimwipe and weighed on a 
microscale prior to enzymatic treatment.  All gels were transferred to separate wells 
of a 24-well tissue culture plate and 1 milliliter of a 2,000 U/ml hyaluronidase 
(Sigma-Aldrich, St. Louis, MO) solution was added to each gel.  At each time point 
hydrogels were transferred to positively charged microscope slides and carefully 
blotted with a kimwipe before measuring the remaining mass.  Time points for pure 
HA hydrogels were taken every 15 minutes until full degradation of the hydrogel 
network occurred.  Time points for HA-PEGDA co-gels were taken every hour until 
full degradation was observed.  
3.1.5 Swelling Studies 
A protocol used by Tan et. al. was modified to obtain swelling ratios (Q) of 
degradable hydrogels [39].  The following hydrogels were formulated as described 
above: 1%HA, 1.5%HA, 2%HA, 1%HA-2%PEGDA, 1.5%HA-2%PEGDA, 1%HA-
3%PEGDA, and 1.5%HA-3%PEGDA.  Hydrogels were allowed to swell in 1 milliliter 
of PBS at 37:C for 72 hours.  PBS was changed after the first 24 hours to remove 
excess polymer remnants.  Swollen hydrogels were carefully blotted on a kimwipe 
and swollen weights (Ms) were obtained with a microscale.  These hydrogels were 
then transferred to 1.5 milliliter microcentrifuge tubes and frozen at -20:C for ~2 
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hours followed by a freezing at -80:C overnight.  Using a 22 gauge needle tip, a hole 
was made in the caps of the centrifuge tubes and samples were freeze-dried for ~24 
hours.  Dry weights (Md) were then obtained by carefully weighing lyophilized 
hydrogels with a microscale.  The mass-based swelling ratio was defined as 𝑄 =  
𝑀𝑠
𝑀𝑑
 
[40]. 
3.1.6 Compressive Modulus 
 Hydrogels and co-gels were formulated, as described above, and allowed to 
swell in PBS for 72 hours.  The compressive modulus of hydrogels was measured 
using Instron® In-Spec 2200 benchtop apparatus and a Sony CLIÉ® Handheld 
device.  Gels were compressed at a rate of 0.001mm/second.  Load and compression 
values were recorded in the Sony CLIÉ® Handheld device and then transferred into 
text and Excel files.  Stress was calculated using the following equation: 𝜎 =  
𝐹
𝐴
 , 
where F is the force in Newtons and A is the area of the hydrogel.  Strain was 
calculated with the following equation: 𝜀 =  
𝛥𝑙
𝑙𝑜
, where Δl is the recorded 
compression (mm) and lo is the initial height (mm) of the hydrogel.  The 
compressive modulus was determined by plotting stress versus strain and 
determining the slope of the first linear portion of the graph. 
3.2. Mouse embryonic stem cell culture and expansion 
3.2.1 Feeder layer culture and inactivation 
The use of a feeder layer or leukemia inhibitory factor (LIF) is necessary to 
maintain stem cells in an undifferentiated state [41].  Initially a feeder layer of 
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mouse embryonic fibroblasts, STO (Sandoz inbred mouse thiguanine-resistant 
ouabain-resistant) cells, were irradiated and utilized.  The feeder layer was then 
changed to another mouse embryonic fibroblast line, MEFs.  5 x105 MEF cells were 
seeded on two gelatin-coated T-25 tissue culture flasks.  Media was changed every 
2-3 days and MEFs were allowed to grow to ~80% confluency before inactivation 
with mitomycin C or passaging.  One T-25 flask of confluent MEFs was inactivated 
with a 10 µg/ml mytomycin C solution in DMEM with 5% embryonic stem cell 
screened defined Fetal Bovine Serum (ES-screened FBS) (StemCell Technologies, 
Vancouver, BC, CA), for approximately 3 hours at 37:C.  After 3 hours, cells were 
rinsed with sterile PBS and replaced with MEF growth medium.  The second T-25 
flask of MEFs was passaged at a ratio of 1:6 onto two gelatin-coated T-75 tissue 
culture flasks.  After these flasks reached confluency, they were inactivated with 
mytomycin C as previously described.  Inactivated flasks were utilized during mESC 
expansion. 
3.2.2 Expansion of undifferentiated R1 mESCs 
The mESC cell line, R1, (A. Nagy, Mount Sinai Hospital, Ontario, Canada) was 
cultured with similar methods described by Taqvi et. al. [3].  mESCs were cultivated 
on a feeder layer of mitomycin C inactivated MEFs (I-MEFs) in R1/MEF medium 
consisting of complete DMEM medium (Hyclone, Logan, UT) with 20% defined ES-
screened FBS (StemCell Technologies, Vancouver, BC, CA), 2mM L-glutamine, 1mM 
sodium pyruvate, 0.1mM non-essential amino acids, 5 x10-5 2-mercaptoethanol 
(Invitrogen, Carlsbad, CA), 100 U/ml penicillin G (Hyclone, Logan, UT), and 10 µg/ml 
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streptomycin (Hyclone, Logan, UT).  The addition of 1,000 U/ml LIF maintains the 
R1 cells in an undifferentiated state.  5 x 105 – 1 x 106 R1 cells were seeded on a T-
25 flask of I-MEFs and allowed to culture for two days at 37⁰C, 5% CO2 with daily 
medium changes.  After 2 days, R1 cells were passaged at a 1:6 ratio onto two T-75 
flasks of I-MEFs and allowed to culture for two more days before proceeding to the 
pre-differentiation step. 
3.2.3 Pre-differentiation of R1 mESCs  
The first step of pre-differentiation is the removal of feeder cells from 
expanded R1 mESCs.  R1 cells cultured on top of I-MEFs were trypsinized for ~2 
minutes at 37:C and pelleted at 4:C for 5 minutes at 300 x g.  Pellets were 
resuspended in R1 expansion medium and replated in 10 milliliters R1/MEF 
medium onto two T-75 tissue culture flasks without gelatin coating.  Flasks were 
allowed to incubate at 37:C, 5% CO2 for 10 minutes to allow feeder cells to adhere to 
the flask.  The medium was removed from each flask and non-adherent cells were 
pelleted as previously stated.  Cell numbers were obtained using a hemocytometer.  
R1 cells were then seeded onto gelatin-coated T-150 tissue culture flasks at a 
density of 1 x 106 cells per flask.  R1 cells were cultured for two days in R1 pre-
differentiation medium consisting of complete IMDM medium (Hyclone, Logan, UT), 
15% defined ES-screened FBS (StemCell Technologies, Vancouver, BC, CA), 0.1mM 
non-essential amino acids, 5 x 10-5 2-mercaptoethanol (Invitrogen, Carlsbad, CA), 
100 U/ml penicillin G, and 10 µg/ml streptomycin.  Medium was supplemented with 
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1,000 U/ml of LIF.  After two days, R1 pre-differentiated cells were trypsinized for 
~2 minutes at 37:C, 5% CO2 and collected for use in differentiation experiments. 
 
3.3 Mouse embryonic stem cell differentiation 
3.3.1 Embryoid body formation 
To promote EB formation, a modified version of the protocol used by Liu et. 
al. was followed to create two-dimensional (2D) controls.  R1 cells were seeded on 
100 mm bacteriological plastic plates at a density of 1 x 105 cells per milliliter.  Cells 
were cultured in 10 milliliters of R1 differentiation medium used by Liu et. al. 
containing complete IMDM medium (Hyclone, Logan, UT), 15% ES-Cult FBS (Stem 
Cell Technologies, Vancouver, BC, Canada), 2mM L-glutamine, 100 U/ml penicillin G, 
10 µg/ml streptomycin, 0.1mM non-essential amino acids, and 5x10-5 2-
mercaptoethanol.  To promote differentiation, the medium was not supplemented 
with LIF.  Medium was changed every 3 to 4 days by pipetting out all 10 milliliters of 
the EB-media solution into 15 milliliter centrifuge tubes.  These tubes were closed 
and left open by quarter turn before placing them at 37:C, 5% CO2 for 
approximately 30 minutes to allow the EBs to fall.  After gravitational pelleting, 5 
milliliters of medium was removed from the top of the pellet and replaced with a 
fresh 5 milliliters of medium.  The pellet was resuspended with gentle pipetting and 
returned to the 100 mm bacteriological plate for further culture.  
  
18 
 
3.3.2 mESC encapsulation 
As previously stated, an essential step in in vitro differentiation is the 
formation of EBs.  In a hydrogel culture system, EBs can be formed after seeding 
stem cells inside the gel.  R1 expansion and pre-differentiation was followed by 
photoencapsulation, as described above, at a concentration of approximately 1 x 106 
cells per hydrogel.  After gelation occurred, the resulting hydrogels were removed 
from the sterile, 96-well tissue culture plates and transferred to individual wells of a 
24 –well tissue culture plate.  1 milliliter of R1 differentiation medium was added to 
each well.  Samples were then incubated at 37:C, 5% CO2 for two to three hours 
after which medium was changed to remove any hydrogel and photoinitiator 
remnants which may have leached out.  mESC encapsulated hydrogels were 
cultured for various time points including days 3, 7, and 10 depending on the assay 
being performed. 
 
3.4. Microscopy Imaging 
3.4.1 Cell fixation in hydrogels   
Cells and EBs were fixed in hydrogels to allow for both DAPI staining and 
scanning electron microscopy.  Hydrogels were transferred to separate wells of a 
24-well tissue culture plate and underwent three series of five minute PBS rinses.  1 
milliliter of a 4% paraformaldehyde solution was added to each gel.  The gels were 
incubated on ice in the fixative for 15 minutes followed by either DAPI staining or 
another three series of five minute PBS rinses.  Fixed gels were stored at 4:C. 
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3.4.2 DAPI staining   
Encapsulated R1 cells in 1.5%HA – 3%PEGDA gels were fixed as described 
above.  Using a modified version of the protocol from the manufacturer (Molecular 
Probes), encapsulated cells were stained on ice with ~600 µl of a 14.3 mM stock 
solution of DAPI dihydrochloride for 10 minutes.  Hydrogels then underwent three, 
5 minute PBS rinses to remove any excess staining.  Hydrogels were stored at 4:C 
until sample preparation for confocal microscopy.  Silicon spacers (Invitrogen, 
Carlsbad, CA) were stacked on a microscope slide to create a chamber for each 
hydrogel.  Hydrogels were placed in the circular chambers of the spacers and one 
drop of Vectashield mounting medium for fluorescence (Vector Laboratories, Inc., 
Burlingame, CA) was added to each chamber to eliminate any background signal.  A 
cover slip was carefully placed on top of the samples to avoid any air bubble 
formation and clear nail polish was used to seal the cover slip.  The Core facility’s 
confocal microscope (University of Texas Core facility) was used to obtain 
fluorescent and Normalsky images of EBs and cells encapsulated in 1.5%HA – 3% 
PEGDA hydrogels. 
3.4.3 Scanning electron microscopy  
Cells and EBs encapsulated in the hydrogels were fixed as described above.  
Hydrogels were dehydrated using a series of ethanol washes.  The following ethanol 
dilutions were used:  30%, 50%, 60%, 70%, 80%, 90%, and 100%.  Hydrogels were 
transferred to separate wells of a 12-well tissue culture plate.  1 milliliter of 30% 
ethanol was added to each well and was incubated at room temperature for 30 
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minutes.  The ethanol was then removed and 50% ethanol was added.  The same 
procedure was followed for all subsequent dilutions of ethanol.  After the hydrogels 
were fully dehydrated, they were mounted on SEM stubs and stored in a dessicator 
until sputter coating and imaging.  Mounted and dried hydrogels were sputter 
coated with Platinum-Palladium or Iridium using the sputter coater at the Core 
facility (University of Texas Core facility).  SEM images were obtained with the Core 
facility’s instrument, Zeiss Supra 40 VP . 
 
3.5. Cell viability and proliferation 
3.5.1 Propidium Iodide staining  
To assess cell viability of encapsulated R1 cells, a propidum iodide (PI) stain 
was performed on Day 3.  Cells were collected, washed twice with 1 milliliter of 
FACS buffer, and resuspended in FACS buffer as described below in section C.6.2.  3 
µl of PI was added to each sample immediately before performing flow cytometry 
using the Core facility’s (University of Texas Core Facility) FACS Calibur.  MEF cells 
were used as a positive control. 
3.5.2 Cell proliferation assays 
To assess cell proliferation, the CellTiter 96® AQueous One Solution Cell 
Proliferation Assay kit (Promega) was utilized as well as a Carboxyfluorescein 
diacetate, succinimidyl ester (CFSE) assay (Molecular Probes).  Hydrogels and 2D 
cultures were stained with a tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) and 
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the electron coupling reagent, phenazine ethosulfate.  MTS reacts with cells to form 
formazan crystals in culture medium whose absorbance can be read at 490nm with 
a 96-well plate reader. 
1 x 106 R1 cells were encapsulated in 1.5%HA – 3%PEGDA hydrogels and 1 x 
106 R1 cells were seeded on bacteriological plates to promote EB formation in 2D 
cultures as described above.  A set of blank 1.5%HA – 3%PEGDA hydrogels (without 
encapsulated cells) was made as a control.  Cells and hydrogels were kept in culture 
at 37⁰C, 5% CO2 for 3 days.  All hydrogel samples were transferred to separate wells 
of a 48-well tissue culture and 200 µl of R1 differentiation medium was added to 
each sample.  2D control cells were transferred to 15 ml centrifuge tubes and spun 
down at 4:C, 300 x g for 5 minutes to obtain a tight pellet.  The pellet was then 
resuspended in 200 µl of R1 differentiation medium and transferred to separate 
wells of a 96-well plate.  200 µl of R1 differentiation medium was added to three 
wells of the 96-well plate as a control.  40 µl of MTS solution was added to each 200 
µl sample and allowed to incubate at 37:C, 5% CO2 for ~3 hours.  Culture medium 
from the hydrogel samples was removed and transferred to the 96-well plate.  
Absorbance values were recorded at 490 nm with a 96-well plate reader (OpsysMR, 
Thermo Labsystems, Philadelphia, PA). 
To analyze proliferation of encapsulated gels compared to 2D control 
cultures, a CFSE labeling was performed following the protocol provided by 
Molecular ProbesTM.  Prior to cell encapsulation, predifferentiated R1 cells were 
labeled following trypsinization and cell pelleting.  Pelleted cells were resuspended 
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in warm PBS containing 0.1% bovine serum albumin (BSA) at a density of 1 x 106 
cells per milliliter.  A 5mM stock solution of CFSE in sterile DMSO was prepared and 
2 µl of the stock solution was added per milliliter of cells in PBS.  The cells were 
incubated at 37:C, 5% CO2 for 10 minutes, quenched with the addition of 5 volumes 
of cold R1 differentiation medium, and incubated on ice for 5 minutes.  Cells were 
then pelleted and washed three times with cold R1 differentiation medium.  Cells 
were then resuspended and utilized for cell encapsulation in 1.5%HA-3%PEGDA 
hydrogels as well as 2D cultures.  Unlabelled hydrogel cultures, 2D cultures, and 
undifferentiated R1 cells were used as negative controls.  Labeled undifferentiated 
R1 cells were used as a positive control. 
Cells were released from hydrogels through degradation in ~2.5 milliliters of 
a 2,000 U/ml hyaluronidase (Sigma-Aldrich, St. Louis, MO) solution overnight.  Cells 
were pelleted, rinsed twice with FACS buffer (described in section 3.6.2), 
resuspended in ~300 µl FACS buffer, and transferred to FACS tubes.  2D cultures 
were transferred to 15 ml centrifuge tubes and pelleted.  These cells were rinsed 
once with PBS before the addition of ~400 µl of Accumax (Innovative Cell 
Technologies, San Diego, CA).  EBs were incubated at 37:C in Accumax for 
approximately 1 hour before the reaction was stopped with the addition of 1 
milliliter of R1 differentiation medium.  The EBs were vigorously pipetted 10-20 
times and then filtered through a 40 µm mesh to obtain a single cell suspension.  
Single cells were then rinsed twice with FACS buffer, resuspended in ~300 µl of 
FACS buffer, and transferred to FACS tubes.  Undifferentiated R1 cells were labeled 
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with CFSE following the protocol above on the day of FACS analysis.  All samples 
were run on the FACS Calibur in the Core facility (University of Texas Core Facility). 
 
3.6 Hematopoietic stem cell marker analysis 
3.6.1 Collection of cells and EBs from HA-PEGDA hydrogels   
EBs were collected from 2D cultures by transferring the EB-media solution to 
15 ml centrifuge tubes and incubating at 37:C, 5% CO2 for 30 minutes to allow EBs 
to fall to the bottom of the tube.  The supernatant was then removed and the EB 
pellet was washed with 1 milliliter of PBS.  The EB-PBS solution was allowed to 
incubate at 37:C, 5% CO2 for 15 minutes to allow EBs to collect at the bottom of the 
tube again.  EBs underwent an Accumax treatment as described in section 3.5.2.  The 
40 µm same mesh was used for multiple samples of the same condition and the 
mesh was washed with 1 milliliter of medium or PBS between samples.  The single-
cell solution was transferred to a 15 ml centrifuge tube and kept on ice until trypan 
blue staining and cell counting with a hemocytometer. 
 Cells and EBs were collected from hydrogels through enzymatic degradation 
as described above.  Released cells and EBs were pelleted and rinsed once with PBS.  
300 µl of Accumax was added to each pellet and allowed to incubate for ~ 1 hour at 
37:C.  The reaction was stopped with 1 milliliter of R1 differentiation medium and 
single-cell suspensions were obtained with a 40 µm mesh as described above.  
Single-cell solutions were again transferred to 15 ml centrifuge tubes and kept on 
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ice until trypan blue staining and cell counting with a hemocytometer was 
performed. 
3.6.2 FACS staining and analysis  
Cells were stained for the surface markers, c-kit and sca-1 (BD Pharmingen), 
as well as for the intracellular marker Oct-3/4 (R&D Systems, Minneapolis, MN).  
Cells were also stained with isotype controls for the three markers (BD 
Pharmingen).  A minimum of 2 x 105 cells are necessary for flow cytometry.  To 
ensure this number of cells was obtained from each sample, cell numbers from all 
samples were obtained.  To create FACS controls, extra cells from all samples were 
pooled and aliquotted to make FACS controls.  The following separate FACS controls 
for cells released from hydrogels and 2D cultures were created: single-stained, 
unstained, and isotype controls.  Cells from each sample were pelleted and then 
washed twice with cold FACS buffer (1% BSA, 0.05% Sodium Azide in PBS).  After 
the first wash, samples were transferred to 1.5 ml or 2.0 ml microcentrifuge tubes.  
Following the second wash, samples were resuspended in ~ 50 µl of FACS buffer 
before proceeding with cell surface marker staining. 
 Samples were first blocked on ice for 10 minutes to prevent non-specific 
antibody binding by adding 1 µl of FcBlock (BD Pharamingen) to each sample.  1 µl 
of antibodies for ckit-APC and sca-1-PE was then added to each sample in dark 
conditions and allowed to incubate on ice for 30 minutes.  Isotype control antibodies 
were added to the isotype control samples in the same manner.  If no intracellular 
staining was performed, samples were washed twice with 500 µl of ice-cold FACS 
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buffer and resuspended in 150 µl FACS buffer.  Cells were then fixed by adding 150 
µl of 2% paraformaldehyde to each sample and transferring samples to FACS tubes.  
Samples were stored in the dark at 4:C until flow cytometry was performed. 
 For intracellular marker staining an intracellular staining kit (eBioscience) 
was used and a modified version of eBioscience’s protocol was followed.  After cell 
surface marker staining was completed, each sample was washed once with 1 ml of 
ice-cold FACS buffer.  The supernatant was poured off and the remaining volume 
and cell pellet were pulse vortexed.  900 µl – 1 ml of Fixation/Permeabilization 
solution was added to each sample and incubated at 4:C for ~45 minutes.  Samples 
were then washed twice with 1.5 mls 10x Permeabilization Buffer or once with 4 
mls of Permeabilization buffer.  1 µl of the Oct-3/4 antibody was then added to each 
sample and incubated on ice for 30 minutes.  Samples were then washed twice with 
500 µl FACS buffer and resuspended in a final volume of 300 µl before transferring 
to FACS tubes.  All samples were stored in the dark at 4:C until flow cytometry was 
performed. 
 
3.7 Gene expression analysis 
3.7.1 RNA isolation and DNase treatment  
RNA was isolated from cell samples using TRIzolTM (Invitrogen, Carlsbad, CA) 
and the protocol provided by Invitrogen.  Briefly, cells and EBs released from 
degraded hydrogels were pelleted and the supernatant was removed.  1 milliliter of 
TRIzolTM reagent was added to the cell pellets, pipetted several times to assist in 
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chemical lysing of cells, and incubated for 5 minutes at room temperature to assure 
cell lysing.  The lysed cells were stored in 1.5 milliliter nuclease-free 
microcentrifuge tubes at -80:C before proceeding with RNA extraction.  To separate 
organic phases from aqueous phases a phenol-chloroform extraction was 
performed.  Briefly, 200 µl of chloroform was added to each sample and incubated at 
room temperature for 2-3 minutes.  Samples were centrifuged at 12,000g, 4:C for 15 
minutes followed by transfer of the aqueous phase to separate 1.5 milliliter 
nuclease-free microcentrifuge tubes.  500 µl of isopropanol was then added to the 
samples and centrifuged as above to pellet the RNA.  1 milliliter of 75% ethanol was 
added to wash all RNA samples.  After centrifugation at 7,500 x g for 5 minutes, the 
ethanol was poured off and RNA pellets were allowed to air dry for up to 30 
minutes.  Dried pellets were resuspended in 10 µl of nuclease-free water. 
 To remove any DNA from the RNA samples a DNase treatment was 
performed using the TURBO DNase kit (Ambion, Austin, TX).  The protocol provided 
by the company was followed.  Briefly, 1 µl of TURBO DNase buffer was added to 
each RNA sample followed by the addition of 1 µl of the TURBO DNase enzyme.  
Samples were transferred to 0.5 milliliter nuclease-free microcentrifuge tubes and 
were then placed in a 37:C water bath and allowed to incubate for approximately 25 
minutes.  To stop the enzymatic reaction, 1.1 µl of the DNase inactivation reagent 
was added.  Samples were centrifuged at 10,000 x g for 90 seconds.  The aqueous 
supernatant was removed (~ 7 – 10 µl) and transferred to new 0.5 milliliter 
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nuclease-free microcentrifuge tubes.  Quantity and purity of RNA was assessed after 
this treatment using the Nanodrop (ND-1000, University of Texas Core Facility). 
3.7.2 Real-time polymerase chain reaction  
Equal quantities of RNA for each sample were reversed transcribed using a 
cDNA synthesis kit (SABiosciences, Frederick, MD).  For real-time polymerase chain 
reaction (RT-PCR), 0.5 µl of primers for cKit and sca-1 were added to 7.5 µl RT2 
SYBR Green ROX Master Mix (SABiosciences, Frederick, MD), 6.0 µl dH2O, and 0.75 
µl cDNA.  Each 15 µl sample was pipetted into a 386-well PCR plate and cycled using 
the following program on the ABI 7900HT RT-PCR machine (University of Texas 
Core Facility): 1 cylce for 10 minutes at 95:C, 40 cycles for 15 seconds at 95:C 
followed by 1 minute at 60:C.  Threshold values were obtained using SDS 2.2.1 
software (Applied Biosystems, Foster City, CA). 
3.7.3 Real-time polymerase chain reaction microarray analysis  
RNA was isolated as described above and the protocol provided by 
SABiosciences Corporation was followed.  Briefly, synthesized cDNA was diluted in 
91µl of nuclease-free water and mixed with 1275 µl RT2 SYBR Green ROX Master 
Mix and 1173 µl dH2O.  25 µl of solution was added to each well of the 96-well 
Mouse Embryonic Stem Cell RT2 ProfilerTM PCR Array.  The same RT-PCR machine, 
cycling program, and gene expression analysis software as above was utilized.   
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Chapter 4:  Results and Discussion 
 
4.1 Hydrogel chemical and physical characterization  
4.1.1 Proton Nuclear Magnetic Resonance of Methacrylated HA 
Proton nuclear magnetic resonance (1H-NMR) was conducted on MeHA to 
verify methacrylation of HA.  A 1H-NMR was also performed on HA to serve as a 
reference spectra.  The percent methacrylation of each reaction was calculated by 
taking the ratio of methacrylated molecules to the total number of disaccharide 
units.  Total number of disaccharide units was found by summing the integral of the 
methyl peaks (~1.7-1.9 ppm) and dividing by 3, the number of protons associated 
with the HA methyl groups.  Total number of methacrylate groups was calculated by 
summing the integral of the alkene protons (~5.2-5.5 ppm) and dividing by 2.  To 
obtain percent methacrylation, the ratio was multiplied by 100. 
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Figure 4-1.  1H-NMR of Native Hyaluronic Acid. Hyaluronic Acid (MW ~ 2 x 106) (a) peak 
associated with the solvent D20; (b) peak associated with the disaccharide unit. 
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Figure 4-2.  1H-NMR of Methacrylated Hyaluronic Acid. (a) peak associated with the solvent D20; 
(b) peak associated with the disaccharide unit; (c and d) peaks associated with the methacrylate 
groups (~ 5.2 – 5.5 ppm). 
 
Figures 4-1 and 4-2 are the NMR spectra of unmodified HA and MeHA respectively.  
These spectra are comparable to those published by Leach et. al..[38]  Peak “a” on 
both NMR spectra is associated with the solvent D2O.  Peaks labeled “b” on both 
spectra correspond to protons of the disaccharide unit.  Methacrylate groups will 
shift downfield on the NMR.  As shown in the Figure 4-2 inset, two peaks labeled “c” 
and “d” have shifted downfield (~5-6 ppm) in comparison to unmodified HA 
indicating successful methacrylation.  Table 4-1 shows the range of percent 
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methacrylation obtained in separate reactions.  Percentages ranged from ~9% - 
30% which is consistent with values obtained by Leach et. al..[38] 
Table 4-1. Percent Methacrylations from Separate HA Methacrylation Reactions 
Sample Methyl Peaks  Alkene Protons Percent Methacrylation 
Apr-08 3.21 1.00 31.20% 
Jul-08 11.1 1.04 9.35% 
Apr-09 8.26 0.995 12.00% 
 
4.1.2 Determination of degradable hydrogels and degradation profiles 
 In order to observe the affects of the synthetic, biomimetic 
microenvironment on the encapsulated mESC surface markers, a degradable 
hydrogel system was required.  Furthermore, it was necessary to develop a system 
which degraded in 24 hours or less to minimize mESC exposure to factors outside of 
the hydrogel system.  Initial studies were conducted to determine HA hydrogels and 
HA-PEGDA co-gels which met this specification.  An enzyme solution with a 
concentration of 2,000 U/ml of hyaluronidase in growth medium was added to the 
gels and incubated at 37:C for 24 hours.  Table 4-2 shows the hydrogel formulations 
which were shown to be degradable in this time period.  Increasing HA above 2% 
(w/v) created an extremely viscous solution incapable of being pipetted.  Increasing 
PEGDA concentrations above 3% (w/v) produced hydrogels which were not 
degradable in the 24 hour time period.  These results are consistent with those of 
Wieland et. al. who found that co-gels composed of HA-acryl and more than 4% 
(w/v) 4-arm PEG-acryl were considered “mechanically stable” for more than 50 
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days under enzymatic conditions [40].  Only the hydrogel formulations listed in 
Table 4-2 were used in the remaining studies.  
Table 4-2. Degradable HA Hydrogel and HA-PEGDA co-gel Formulations 
HA (%) PEGDA (%) 
1 0 
1.5 0 
2 0 
1 2 
1 3 
1.5 2 
1.5 3 
 
 To fully characterize the behavior of the hydrogels under enzymatic 
conditions, degradation studies were performed.  Figures 4-3 and 4-4 show the 
results of degradation studies.  Pure HA hydrogels and HA-PEGDA co-gels have 
significantly different degradation profiles.  Degradation times of pure HA gels 
ranged between 1.25 and 2 hours while co-gels took between 6 and 16 hours to fully 
degrade.  An unpaired, two-tailed student’s t-test was performed at each time point 
to determine if the degradation profiles of pure HA hydrogels and HA-PEGDA co-
gels were significantly different (p < 0.05).  1%HA gels were the fastest to degrade 
and the degradation profile appears to be exponential in comparison to 1.5%HA and 
2.0%HA whose profiles appear more linear.  1.5%HA and 2.0%HA degrade in very 
similar fashions and their error bars at each time point overlap suggesting that the 
degradation behaviors of these two gels is not significantly different.  This was 
confirmed by examining the p values of 1.5%HA and 2.0%HA hydrogels at each time 
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point.  The masses of both hydrogel formations at all time points were not found to 
be significantly different.  A statistical comparison of masses corresponding to 
1%HA and 2.0%HA hydrogels also showed no significant difference.  The only 
statistically significant difference was found between 1.5%HA and 1%HA hydrogels 
at two time points (0.5 hours and 0.75 hours).  Statistical comparison of the 
degradation profiles indicates that overall, the formulation of pure HA hydrogels 
does not significantly alter the degradation profiles.  The profiles are statistically 
similar with the exception of two time points. 
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Figure 4-3.  In Vitro Degradation profile of pure HA hydrogels. Degradation profiles of pure HA 
hydrogels incubated in 2,000 U/ml hyaluronidase at 37:C.  Masses were measured every 0.25 hours 
until complete degradation occurred.  Each data point is an average value ± standard error (n = 4). 
 
 At the first time point in the co-gel degradation profile (1 hour) all the co-gels 
appear to degrade in the same manner.  This observation was confirmed with a p 
value < 0.05 comparing all hydrogels.  In following time points, the co-gels 
differentiate themselves.  Co-gel degradation profiles show a difference in behavior 
between co-gels containing 2% (w/v) PEGDA and co-gels with 3% (w/v) PEGDA.  
Statistical comparison of 2% (w/v) co-gel masses, revealed no significant 
differences at any time point.  The degradation profiles of 2% (w/v) co-gels cannot 
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be considered different.  In examining profiles associated with 3% (w/v) co-gels, 
statistical analysis at each time point indicated no difference in the hydrogel masses.  
The degradation profiles of 3% (w/v) co-gels are also not different.. 
 There is a significant difference (p <0.05) between 2% (w/v) and 3% (w/v) 
co-gels.  Between hour 2 and hour 9, the degradation profiles of 2% (w/v) co-gels 
and 3% (w/v) co-gels are different.  The degradation profile of 1%HA-3%PEGDA co-
gels can be considered the same as 2% (w/v) co-gels from hour 10 until hour 16.  
From hour 14 until full co-gel degradation at hour 16, the degradation profiles of all 
co-gels can be considered the same (p > 0.05). 
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Figure 4-4.  In Vitro Degradation profile of HA-PEGDA co-gels. Degradation profiles of HA-PEGDA 
co-gels in the presence of 2,000 U/ml hyaluronidase at 37:C.  Masses were measured every hour 
until complete degradation occurred.  Each data point is an average value ± standard error (n = 4 
except for 1%HA-2%PEGDA which has n = 3). 
 
 An apparent trend in the data is an increase in PEGDA results in slower 
degradation.  The enzyme, hyaluronidase, only cleaves the bond between the 
disaccharide units of HA.  Crosslinks created in pure HA gels are only between the 
functional groups of HA molecules.  The introduction of PEGDA into hydrogels 
creates more opportunities for crosslinks between HA functional groups and PEGDA 
functional groups.  HA gels will degrade quickly because all the crosslinks contains 
molecules which will be enzymatically cleaved.  Co-gels will take longer to degrade 
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because not all the crosslinks will contain HA molecules.  Moreover increasing 
PEGDA quantities increases the possibility of crosslinks between PEGDA molecules 
and therefore will lengthen the amount of time for full degradation.  Most 
importantly, this data indicates in detail that all of these hydrogel systems degrade 
in the desired time of 24 hours or less. 
4.1.3 Swelling Ratios 
More than half of the hydrogels formulated contain more than one 
component and therefore, pore size cannot be directly calculated.  A swelling study, 
another method of characterizing pore size, was conducted to calculate the swelling 
ratio of the different hydrogels.  The swelling ratio (Q) was calculated using the 
formula, 𝑄 =
𝑀𝑠
𝑀𝑑
.  An unpaired, two-tailed student’s t-test was performed to 
determine statistically significant differences (p < 0.05) in swelling ratios between 
gels.  Figure 4-5 shows the results of the swelling study. 
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Figure 4-5.  Swelling Ratio of HA hydrogels and HA-PEGDA co-gels. Swelling ratio is a method of 
characterizing the degree of crosslinking and pore sizes in multi-component hydrogels.  The swelling 
ratio was determined by dividing the swollen mass by the dried mass.  (*) swelling ratio significantly 
lower than all pure HA gels and HA-PEGDA co-gels; (**) swelling ratio significantly different from all 
hydrogels except 1%HA-3%PEGDA; (***) swelling ratio significantly lower than all hydrogels except 
2% (w/v) co-gels.  Each data point is an average value ± standard error (n=4 for all hydrogels except 
1%HA and 1%HA-3%PEGDA which have n=3). 
 
 All of the pure HA gel swelling ratios were significantly different from all the 
co-gel swelling ratios indicating pure HA gels are not as tightly crosslinked and are 
able to imbibe more water.  Co-gel swelling ratios are lower than those of pure HA 
gels because of the addition of high molecular weight PEGDA.  An apparent trend in 
the data suggests that the introduction of PEGDA (MW 3400) into the polymer 
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solutions allows for an increase in crosslinks and a tighter mesh network.  This 
decreases the pore sizes of the hydrogel network and results in a decrease in water 
intake.  
Both of the co-gels containing 2% (w/v) PEGDA have a swelling ratio which 
is significantly different from all of the formulated hydrogels with the exception of 
1%HA-3%PEGDA.  Similarly, the 1%HA-3%PEGDA co-gel swelling ratio is 
significantly different from all the formulated hydrogels except the co-gels 
containing 2% (w/v) PEGDA.  The swelling ratios of the 2% (w/v) co-gels and 
1%HA-3%PEGDA hydrogels cannot be considered different indicating that their 
composition was not altered enough to significantly change the mesh network size.  
Only the 1.5%HA-3%PEGDA co-gel has a swelling ratio which is significantly 
different from all formulated hydrogels.  These results indicate that swelling ratio is 
not solely dependent on PEGDA quantities.  Crosslinking of the two polymers is due 
to the presence of functional groups on both the synthetic and natural polymers 
(acrylate and methacrylate groups).  Therefore, the largest increase in both HA and 
PEGDA quantities will result in the tightest crosslinking.   
4.1.4 Scanning electron microscopy 
 Figure 4-6 contains SEM images of dried 1.5%HA-3%PEGDA (a-d) co-gels 
and 1.5%HA hydrogels (e-f).  To obtain these images, hydrogels were dried in two 
fashions: freeze-drying and ethanol dehydration.  Images a-b were prepared 
through an ethanol dehydration method as described in materials and methods.  
Images c-f were dried through lyophilization for ~24 hours.  These images illustrate 
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the porous nature of these hydrogels.  The swelling ratios of HA gels and HA-PEGDA 
co-gels suggest that HA gels should be more porous however, the images in this 
figure do not seem to correspond to that finding.  This could be due to the method of 
drying utilized.  Lyophilization will disrupt the true molecular interactions and 
structure in a relaxed or swollen gel.  The molecular interactions in the HA gel could 
have been disrupted and therefore the SEM images may not be truly representative 
of HA hydrogel porosity.  Also, as described in the background, the super-swelling 
property of HA is a result of water’s interaction with H-bonds between polymer 
chains; the HA hydrogels’ swelling ratios are not solely dependent on porosity. 
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Figure 4-6. SEM images of Dried HA hydrogels and HA-PEGDA co-gels.  (a and b) 1.5%HA-
3%PEGDA hydrogels dried using ethanol dehydration and sputter-coated with Ir; (c and d) 
lyophilized 1.5%HA-3%PEGDA hydrogels sputter-coated with Pt-Pl; (e and f) lyophilized 1.5%HA 
hydrogels sputter-coated with Pt-Pl. 
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4.1.5 Compressive modulus 
 A compressive modulus study was done to determine the mechanical 
stability of the hydrogels.  Figure 4-7 contains the results of this study.   An 
unpaired, two-tailed student’s t-test was performed to determine statistically 
significant (p < 0.05) differences in each hydrogel’s mechanical strength.  There was 
a significant difference between 1.0%HA and 1.5%HA gels with 1.0%HA having a 
significantly lower modulus.  This is most likely a result of increased crosslinking in 
1.5%HA gels imparting more mechanical strength on the gel.  The only statistically 
significant co-gels were 1.5%HA-2%PEGDA and 1.5%HA-3%PEGDA gels.  The 
composition of these gels only differs by 1% (w/v) PEGDA therefore, our 
expectation was that the compressive modulus would not be significantly different.  
The p-value obtained for this pairing was borderline (p = .047).  The variances for 
the groups are so large and the compressive modulus values are too broadly 
distributed to conclusively say, with a small number of tests, that these groups are 
definitively different. 
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Figure 4-7.  Compressive Modulus measurements of HA hydrogels and HA-PEGDA co-gels.  (*) 
The compressive modulus of 1%HA hydrogels was found to be significantly lower (p < 0.05) than 
1.5%HA hydrogels.  Similarly, the compressive modulus of 1.5%HA-3%PEGDA was significantly 
lower (p < 0.05) than 1.5%HA-2%PEGDA. Each data point is an average value ± standard error (n=4 
for 1.5%HA and 1.5%HA-3%PEGDA; n=3 for 1%HA, 1%HA-3%PEGDA, and 1.5%HA-2%PEGDA; n=2 
for 1%HA-2%PEGDA). 
 
4.2 Encapsulated cell viability and proliferation 
4.2.1 MTS assay 
 A calorimetric MTS assay was conducted to measure cell proliferation in the 
hydrogel system (1.5%HA-3%PEGDA) and 2D cultures treated with UV (UV-2D) 
compared to 2D control cultures.  Figure 4-8 illustrates the optical density (OD) 
measurements obtained.  OD measurements of plain media or HA-PEGDA co-gels 
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without encapsulated cells were subtracted out of the remaining measurements to 
eliminate error from background signal.  A standard curve could not be made due to 
the nature of the cells being cultured.  mESCs cultured in a 2D environment form 
EBs, clusters of cells.  To create a standard curve, cell quantities must be known and 
to count the cells in the 2D controls, the EBs must be disrupted by an enzymatic 
treatment (trypsin or accumax).  The treatment process does not completely disrupt 
the EBs and it also results in a considerable amount of cell death (shown in cell 
viability data); cell counts obtained would not be accurate.  Additionally the culture 
systems being assayed will not undergo any enzymatic treatment in an attempt to 
quantify proliferation in each culture system without introducing extrinsic factors.   
To assign a quantitative cell proliferation value to OD measurements, an 
assumption was made.  Since no extrinsic factors (i.e. UV light, polymer, 
photoinitiator) were introduced to the 2D control cultures, cell proliferation in this 
system was assumed to be 100%.  The initial seeding density of each culture system 
was ~1 x 106 cells; therefore, percent proliferation for the hydrogels and UV-2D 
samples could be determined.  Table 4-3 shows percent proliferation.  An unpaired, 
two-tailed student’s t-test was conducted to determine statistically significant (p < 
0.05) differences between groups.  As evidenced by the OD measurements, the 
decrease in cell proliferation in hydrogels compared to both 2D control cultures and 
UV-2D cultures is statistically significant.  Although cell proliferation is reduced in 
the UV-2D samples compared to 2D controls, this difference is not statistically 
significant.  These results suggest that multiple factors are responsible for the 
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decline in encapsulated mESC proliferation.  These factors could include exposure to 
free radicals from the photoinitiator and extensive pipetting with polymer solution.  
The restrictive nature of the hydrogel mesh network may also be responsible.  There 
is no way to conclusively pinpoint the main source of reduced cell proliferation in 
the hydrogel system. 
 
 
Figure 4-8.  Optical density measurements obtained from MTS assay Optical density 
measurements from an MTS assay were obtained using a plate reader.  The ODs of 2D controls and 
UV-treated 2D controls (2D-UV) were corrected by subtracting the OD of plain media.  ODs of 
hydrogels were corrected by subtracting the OD of empty hydrogel controls.  (*) The OD of a 
representative hydrogel (1.5%HA-3%PEGDA) was significantly lower (p < 0.05) than both 2D and 
2D-UV samples.  Each data point is an average value ± standard error (n=3). 
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Table 4-3.  Percent Proliferation of Encapsulated mESCs 
  2D Control 1.5%HA - 3% PEG UV-2D  
OD Corrected to Media or Empty Gel 1.83 1.08 1.57 
Percent Proliferation 100 58.8 85.8 
 
4.2.2 CFSE labeling 
 CFSE labeling of cells in 2D control cultures and hydrogel cultures was 
performed to acquire additional cell proliferation measurements.  Analysis of 
labeling was done with flow cytometry.  Figure 4-9 includes the FACS histograms of 
CFSE labeled 2D control cells (A) and CFSE labeled encapsulated mESC cells (B).  
Figure 4-10 shows the percentages of each cell population present in the histogram.  
An unpaired, two-tailed student’s t-test was done to determine statically significant 
differences in cell population percentages. 
 The CFSE stain will appear around the 103 - 104 region of the histogram.  As 
cells undergo mitotic division, they lose the CFSE labeling and cells without CFSE 
will appear in the 100 – 101 region of the histogram.  Distinct cell populations can be 
seen on the histogram as more cells undergo mitosis and lose CFSE labeling.  As 
illustrated in the FACS histograms (Figure 4-9), mESCs from the 2D controls 
proliferated to the point that CFSE was eliminated from the culture and only one cell 
population remained.  Encapsulated mESCs did not proliferate as efficiently and 
three different populations are present in the culture.   
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Figure 4-9.  FACS histograms of CFSE labeled cell populations. (A) FACS histograms of 2D 
controls. (B) FACS histograms of a representative hydrogel (1.5%HA-3%PEGDA).  Different peaks on 
the histograms are indicative of different cell populations.  Cells retaining the CFSE labeling are found 
in ~103 – 104 region.  As cells proliferate and divide, the CFSE labeling diminishes.  Cells which have 
undergone extensive proliferation are found in ~100 – 101 region.  2D controls lost all CFSE labeling 
while the majority of hydrogel samples retained the CFSE labeling. 
 
As demonstrated by both Figures 4-9 and 4-10, the largest of these 
populations is in the CFSE region of the histogram indicating that the majority of 
encapsulated mESCs did not proliferate.  This again could be the result of a number 
of factors including steps taken during photopolymerization or the restrictive 
nature of the mesh network may not allow for proficient proliferation.  
48 
 
 
Figure 4-10.  Summary of CFSE labeled cell populations.  (*) CFSE labeled population significantly 
lower than 2D controls and 102 – 103 population of hydrogels; (**) 2D controls higher than all 
hydrogel populations. Each data point is an average value ± standard error (n = 3). 
 
4.2.3 Propidium Iodide staining 
 To examine cell viability in hydrogel systems compared to 2D control 
cultures, a propidium iodide (PI) stain was conducted and analyzed with flow 
cytometry.  An unpaired, two-tailed student’s t-test was done to reveal statistically 
significant (p < 0.05) differences in cell viability.  Figure 4-11 shows the cell viability 
results of cells after 3 days of culture.  mESCs from 2D control cultures (2D_set1) 
and 1.5%HA-3%PEGDA hydrogel cultures (Gel_set1) were harvested and subjected 
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to an Accumax treatment as described in materials and methods.  MEF cells 
(positive control) and pre-differentiated mESCs were not subjected to an Accumax 
treatment.  The percentage of live pre-differentiated cells compared to MEF cells 
was not statistically different; therefore, pre-differentiated mESCs, the precursor to 
2D control and hydrogel cultures, can be considered the control group.  The 
decrease in percentage of live cells in 2D control cultures and hydrogel cultures 
compared to pre-differentiated cells is statistically significant.  This assay measures 
cell viability after enzymatic processing and consequently is not a completely 
accurate measurement of viability during the culture itself.  It is rather a 
measurement of cell viability after creating a single-cell suspension which is of value 
in flow cytometric analysis. 
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Figure 4-11.  Percentage of Live Cells in 2D and hydrogel cultures.  Cell viability was obtained by 
staining  positive controls (MEF and R1 predifferentiated cells), 2D controls, and representative 
hydrogels (1.5%HA-3%PEGDA) with propidium iodide and analyzing with flow cytometry.  2D_set1 
and Gel_set1 samples were subjected to Accumax enzymatic treatment.  2D_set2 and Gel_set2 were 
not subjected to Accumax enzymatic treatment. (*) Cell viability significantly lower (p < 0.05) than 
R1 predifferentiated cells; (**) Cell viability significantly lower (p < 0.05) than MEF and R1 
predifferentiated cells; (***) Cell viability significantly lower (p < 0.05) than all samples.  Each data 
point is an average value ± standard error (n=4 for all hydrogel samples; n=3 for positive controls 
and all 2D controls). 
 
The effect of an enzymatic treatment with Accumax was also examined in this 
study.  2D_set2 and Gel_set2 were not subjected to Accumax.  To obtain single-cell 
suspension for FACS analysis, these cells were vigorously pipette and put through a 
cell strainer.  Figure 4-11 shows the decrease in live cell percentage in both these 
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cultures compared to the positive controls and the Accumax treated cultures.  
2D_set2 was only significantly different from the pre-differentiated control but the 
decreased live cell population in Gel_set2 was statistically significant from all 
samples except 2D_set2.  These results suggest an Accumax treatment will 
significantly increase the quantity of live cells in hydrogel cultures after single-cell 
processing but will not increase the live cell population remaining in 2D cultures 
after processing. 
 
4.3 EB formation in hydrogels 
4.3.1 Light microscopy 
Figure 4-12 displays light microscopy images taken to provide qualitative 
evidence of EB formation in the hydrogels at different time points (Day 2, Day 5).  
EB formation in 2D cultures was also imaged.  In all culture conditions EB size 
increased from Day 2 to Day 5.  
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Figure 4-12.  Light Microscopy images of EBs encapsulated in hydrogels.  Representative 
hydrogels and 2D controls were imaged (10X magnification) on Day 2 and Day 5 post-encapsulation 
to monitor EB formation and size.  (a and b) 2D controls; (c and d) 1.5%HA hydrogels; (e and f) 
1.5%HA-3%PEGDA co-gels.  2D controls, hydrogels, and co-gels all have the same initial seeding 
density of 1 x 106 cells. 
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On Day 5 EBs of comparable sizes were observed between 1.5%HA hydrogel 
cultures and 2D control cultures indicating that differentiation was occurring in 
both culture systems.  The size of EBs formed in the 1.5%HA-3%PEGDA co-gel 
culture was much smaller than those in the other systems.  This is most likely due to 
the tight mesh network created with the addition of a high molecular weight PEGDA 
which restricts EB expansion.  Figure 4-13 includes images of cells and EBs (Day 5) 
in the center of the hydrogels and demonstrates the inhibition of EB growth in the 
co-gel cultures in comparison to pure HA gel cultures.  Another observation was the 
tendency of EBs to form near the edges of the hydrogels as shown in Figure 4-12.  
This is the region of the hydrogel with the least physical restriction and allows the 
EBs to expand and proliferate more than EBs captured in the mesh network in the 
hydrogel center. 
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Figure 4-13.  Light microscopy images of encapsulated mESCs at the center of hydrogels.  
Differences in EB formation and size was seen between pure HA hydrogels and HA-PEGDA co-gels.  
EBs tend to form on the edges of hydrogels were there is room for proliferation and expansion; the 
center of hydrogels restrict expansion.  Pure HA hydrogels are less restrictive than co-gels which 
have a tighter mesh network as seen above.  (a) 1%HA; (b) 1.5%HA; (c) 1%HA-3%PEGDA; (d) 
1.5%HA-3%PEGDA.  All images (10X magnification) were obtained on Day 5.  
 
4.3.2 Scanning electron microscopy 
 SEM was also performed on dried hydrogels (1.5%HA-3%PEGDA) containing 
fixed, encapsulated mESCs after 7 days of culture.  Images in Figure 4-14 show 
formation of EBs in the hydrogel.  It was again observed that most of the EBs 
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migrate towards or grow near the edges of the hydrogels.  Images of these EBs were 
captured on the hydrogel surface. 
 
 
Figure 4-14.  SEM images of EBs in 1.5%HA-3%PEGDA co-gels.  SEM images of EBs formed in 
1.5%HA-3%PEGDA hydrogels were obtained on Day 7 post-encapsulation. 
 
4.3.3 Confocal microscopy 
 Confocal microscopy was done to capture images of EB formation in different 
planes of the hydrogel.  Figure 4-15 again demonstrates EB formation in the 
hydrogel culture system.  DAPI staining was also performed to prove the presence of 
nuclei in the EBs.  A representative hydrogel sample, 1%HA-2%PEGDA, was utilized 
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for imaging on Day 7.  The tight mesh network of this hydrogel system inhibits EB 
growth and these EBs are not comparable in size to those found in 2D cultures.  The 
positive DAPI does indicate multiple nuclei confirming the clustering of cells.  
Further imaging experiments can be done with less restrictive gels (i.e. pure HA 
hydrogels) to distinguish differences in EB size amongst hydrogel systems. 
 
 
Figure 4-15.  Confocal images of encapsulated mESCs. (a - c) Day 7 Encapsulated mESCs in 1%HA-
2%PEGDA hydrogels were stained with DAPI to evaluate EB formation. (a) Confocal image of DAPI 
stain; (b) Normalsky image of EB associated with DAPI stain; (c) overlay of DAPI stain and Normalsky 
images obtained using LeicaLite Software. (d – f) Day 12 Normalsky images of encapsulated mESCs 
and EBs formed in 1.5%HA-3%PEGDA hydrogels. 
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4.4 mESC Differentiation 
4.4.1 Flow cytometry 
Cells from 2D control cultures and hydrogel cultures were fluorescently 
tagged with antibodies for cell surface markers c-kit and sca-1 and the intracellular 
marker, Oct-3/4, after 10 days in culture.  The presence of Oct-3/4 in cells indicates 
stem cell maintenance.  The existence of a double positive population (c-kit+/sca-1+) 
would designate hematopoietic differentiation in the culture.  Samples were run 
through a flow cytometer and results were analyzed with the flow cytometry 
software, FlowJo.  Figures 4-16 and 4-17 show the FACS results of two separate 
experiments with the exact same culture conditions.  Both experiments were 
stopped on Day 10 and cell seeding density was constant.  An unpaired, two-tailed 
student’s t-test was used to determine statistically significant (p < 0.05) differences 
between hydrogel cultures and 2D controls in each experiment. 
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Figure 4-16.  Expression of intracellular stem cell maintenance marker Oct-3/4 in 2D control 
and 3D hydrogel cultures.  Flow cytometry analysis shows the level of expression in 2D control 
cultures and hydrogel systems.  Blue bars and red bars are expression levels from two separate 
experiments, 1 and 2. (*) Oct-3/4 expression significantly different between experiments; (**) Oct-
3/4 expression siginificantly different between hydrogel samples and 2D controls of experiment 1; 
(***) Oct-3/4 expression siginificantly different between hydrogel samples and 2D controls of 
experiment 2. Each data point is an average value ± standard error (n = 3). 
  
A comparison of 2D control culture Oct-3/4 expression in both experiments 
reveals a drastic decline in percentage of Oct-3/4+ cells.  Results from the first 
experiment demonstrate a significant decrease in Oct-3/4+ cells in hydrogel culture 
while results from the second experiment suggest an increase in Oct-3/4+ in 
hydrogel culture compared to 2D cultures.  The data from these experiments 
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appears conflicting; however, the percentage of Oct-3/4+ cells in hydrogel cultures is 
consistently low.  The percentage of Oct-3/4+ cells in all hydrogel samples ranges 
from only ~8% - 17% of the total cell population.  Also, 1.0%HA and 1.5%HA 
hydrogels were examined in both experiments and there was no significant 
difference in total Oct-3/4+ cells in these cultures between experiments.  Although 
the 2D culture Oct-3/4+ population varied greatly between experiments, the data 
illustrates small percentage of Oct-3/4+ cells in all culture conditions suggesting the 
occurrence of some form of differentiation in all culture systems. 
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Figure 4-17.  Expression of double positive cells for stem cell surface markers c-kit and sca-1 
in 2D control and 3D hydrogel cultures.  Flow cytometry analysis shows the level of expression in 
2D control cultures and hydrogel systems.  Blue bars and red bars are expression levels from two 
separate experiments, 1 and 2. (*) c-kit+/sca-1+ expression significantly different between 
experiments; (**)c-kit+/sca-1+ expression siginificantly different between hydrogel samples and 2D 
controls of experiment 1; (***) c-kit+/sca-1+ expression siginificantly different between hydrogel 
samples and 2D controls of experiment 2. Each data point is an average value ± standard error (n = 
3). 
 
In experiment 1 the c-kit+/sca-1+ double positive (DP) population in all 
hydrogel conditions used (1%HA, 1.5%HA, all 3% (w/v) co-gels) significantly 
decreased in comparison to 2D control cultures.  The second experiment only 
showed a significant decrease in 1%HA and 1%HA-2%PEGDA hydrogel cultures.  
While the DP population for both 1.5%HA hydrogels and 1.5%HA-2%PEGDA co-gels 
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in this experiment was not significant, the error on these sample are large compared 
to the means.  Moreover, 1.5%HA hydrogel DP populations from the two 
experiments were not significantly different.  This data suggests that the DP 
population decreases when mESCs are encapsulated but a decisive conclusion 
cannot be reached from this data and further repeats of this experiment must be 
conducted. 
 Figures 4-18 and 4-19 show the percentage of single positive c-kit and single 
positive sca-1 populations in the two experiments conducted.  C-kit expression data 
from the two experiments is contradicting.  In experiment 1, c-kit was shown to be 
significantly upregulated in the 3% (w/v) co-gel systems; experiment 2 
demonstrated a significant decline in c-kit expression across all hydrogel systems 
with the exception of 2%HA.  
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Figure 4-18.  Expression of single positive cells for stem cell surface marker c-kit in 2D control 
and 3D hydrogel cultures.  Flow cytometry analysis shows the level of c-kit expression in 2D 
control cultures and hydrogel systems.  Blue bars and red bars are expression levels from two 
separate experiments, 1 and 2. (*) c-kit expression significantly different between experiments; (**) 
c-kit expression siginificantly different between hydrogel samples and 2D controls of experiment 1; 
(***) c-kit expression siginificantly different between hydrogel samples and 2D controls of 
experiment 2. Each data point is an average value ± standard error (n = 3). 
 
In experiment 1, sca-1 expression dropped notably in the 3% (w/v) co-gel 
systems.  Experiment 2, revealed a significant decrease in sca-1 expression only in 
1.5%HA hydrogels.  Both of the single positive data sets are inconclusive and a trend 
cannot be determined from cell marker expression analysis; therefore, expression of 
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genes encoding for c-kit and sca-1 markers was conducted and will be discussed 
later in this thesis. 
 
 
Figure 4-19.  Expression of single positive cells for stem cell surface markers sca-1 in 2D 
control and 3D hydrogel cultures.  Flow cytometry analysis shows the level of sca-1 expression in 
2D control cultures and hydrogel systems.  Blue bars and red bars are expression levels from two 
separate experiments, 1 and 2. (*) sca-1 expression significantly different between experiments; (**) 
sca-1 expression siginificantly different between hydrogel samples and 2D controls of experiment 1; 
(***) sca-1 expression siginificantly different between hydrogel samples and 2D controls of 
experiment 2. Each data point is an average value ± standard error (n = 3). 
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 The presence of EBs evidenced through light microscopy, SEM, and confocal 
microscopy coupled with the Oct-3/4 data does suggest that differentiation is 
occurring in the hydrogels.  However, the FACS data implies that the hydrogel 
culture systems are not as efficient at generating HSCs compared to 2D control 
cultures; the mESCs are not differentiating into the hematopoietic lineage.  To 
attempt to determine the lineage which these cells are differentiating into a gene 
expression analysis was conducted. 
4.4.2 PCR arrays 
The RT2 PCR Profiler Array for Embryonic Stem Cells was utilized to look at 
Day 7 up-regulation and down-regulation of genes associated with specific lineage 
markers as well as genes associated with stem cell maintenance, pluripotency, and 
self-renewal.  Data was analyzed and statistical significance was determined using 
the Web-Based PCR Array Data Analysis software from SABiosciences.  Included in 
the 84 genes on this array were primers Pou5f1 (the gene coding for Oct-3/4).  
Figure 4-20 illustrates the down-regulation of both this gene in hydrogel cultures 
compared to 2D control cultures.  Although, none of these results were statistically 
significant (p < 0.05) the down-regulation of Pou5f1 corresponds with the FACS 
data showing decreased expression of Oct-3/4 indicating again that differentiation 
is occurring.  
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Figure 4-20.  Down-Regulation of Pou5f1.  RT-PCR array analysis of the Pouf51, the gene encoding 
for intracellular stem cell maintenance marker, Oct-3/4 shows gene expression of encapsulated cells 
in HA hydrogels and HA-PEGDA hydrogels in comparison to 2D control cultures.  No gene expression 
values  were found to be significantly different from 2D controls.  Data was analyzed with 
SABiosciences web-based PCR Array data analysis software. 
 
 The only statistically significant data obtained from the 84 gene PCR array 
involved genes for blood lineage markers: Hemoglobin X, alpha-like embryonic 
chain in Hba complex (Hba-x) and Hemoglobin Y, beta-like embryonic chain (Hbb-
y).  Figure 4-21 displays the down-regulation of these two genes in hydrogels 
compared to 2D cultures. 
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Figure 4-21.  Down-Regulation of Blood Lineage Genes.  RT-PCR array analysis of 84 genes shows 
down-regulation of Hba-x and Hba-y, genes associated with the blood lineage, in HA and HA-PEGDA 
hydrogel cultures in comparison to 2D control cultures. (*) Gene expression down-regulation 
statistically significant (p < 0.05) in comparison to 2D cultures.  Data was analyzed with 
SABiosciences web-based PCR Array data analysis software. 
 
4.4.3 Real-time polymerase chain reaction 
 RT-PCR was performed with primers for c-kit and sca-1; β-actin was used as 
a housekeeping gene.  Fold change was calculated with the ΔΔCt method using the Ct 
values associated with 2D culture samples as control.  Statistical significance (p< 
0.05) was determined with a two-tailed, unpaired student’s t-test.  Figure 4-22 
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shows Day 7 gene fold change for c-kit and sca-1 in comparison to 2D culture gene 
expression levels. 
 
Figure 4-22.  Gene Fold Regulation of Encapsulated mESCs.  RT-PCR analysis genes encoding for 
stem cell markers, c-kit and sca-1, shows gene fold change in HA and HA-PEGDA hydrogel cultures in 
comparison to 2D control cultures.  No gene fold changes were found to be significantly different.  
Each data point is an average value ± standard error (n = 3).  Samples were run in triplicate.  Data 
was analyzed using the ΔΔCt method.  
 
The data reveals an up-regulation ranging from ~ 1-fold – 7-fold of the gene 
encoding for c-kit (Kit oncogene) across all hydrogel systems; however, KIT 
oncogene fold changes did not significantly differ across the hydrogel systems.  The 
gene encoding for sca-1 (Ly6a) appears to not be up-regulated in the hydrogel 
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systems with fold change values ranging from ~ 0.1 – 1.3.  Up-regulation of only one 
of the hematopoietic markers is not sufficient to produce DP cells.  These results are 
consistent with the DP FACS data revealing diminished DP cell populations in 
hydrogel systems.  It is important to note that these gene expression trends are only 
slightly more conclusive than the preceding FACS data.   
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Chapter 5: Conclusion 
 A major hurdle to overcome in the field of regenerative medicine is the 
availability of a donor cell sources.  Embryonic stem cells are capable of indefinite 
self-renewal and differentiation into any cell lineage making them an extremely 
attractive cell source in the field; however, driving the differentiation process to a 
specific lineage is a complicated process.  Multiple factors may be responsible for 
lineage-specific differentiation including extrinsic physical and chemical factors, 
intrinsic cell signaling, cell-cell cross-communication, and receptor-ligand 
interactions.  While a pluripotent cell source does essentially provide the researcher 
with a “blank slate” it also introduces another obstacle in lineage-specific 
differentiation: the potential of differentiation into multiple cell types, including or 
not including the lineage of interest.  This thesis focused on elucidating the effects of 
a synthetic, biomimetic bone marrow microenvironment on mESC differentiation 
into the hematopoietic lineage. 
 The goal of this thesis was to produce a biocompatible hydrogel system 
which promotes hematopoietic differentiation of mESCs.  Different variations of HA 
hydrogels and HA-PEGDA co-gels were formulated to develop microenvironments 
with varying pore sizes and degradation profiles in an attempt to determine the 
optimal hematopoietic 3D culture system.  Although it was proven that these 
hydrogel systems provide a biocompatible microenvironment capable of 
maintaining a viable cell population with proliferative capacities, they are not 
efficient hematopoietic differentiation vehicles.   
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FACS data indicated a decreased expression of hematopoietic cell surface 
markers and RT-PCR revealed the up-regulation of Kit oncogene only.  For effective 
hematopoietic differentiation, up-regulation of both Kit oncogene and Ly6a is 
necessary to express both hematopoietic cell surface markers, c-kit and sca-1.  It 
appears that this system is not an effective hematopoietic differentiation cell culture 
system; however, data showing a decrease in Oct-3/4 expression and down-
regulation of its gene, Pou5f1, as well as the formation of EBs in hydrogels suggests 
that differentiation is occurring in these 3D culture systems.  PCR arrays were 
utilized in an attempt to identify which lineage encapsulated mESCs were being 
driven towards or if encapsulated mESCs were maintaining “stemness”.  The results 
obtained from the PCR array revealed that not only were none of the 84 genes 
markedly up-regulated but the only genes significantly down-regulated were those 
associated with the blood/hematopoietic lineage.  Unfortunately, the PCR arrays did 
not provide any further information regarding lineage-specific differentiation of 
encapsulated mESCs.  Additional cell marker and gene expression studies are 
necessary to confirm the results presented in this thesis.  
Embryonic stem cells were cultivated in microenvironment similar to the 
native bone marrow, the anatomical site of hematopoeisis, but environmental cues 
presented to the cells were not sufficient to drive them towards the hematopoietic 
lineage.  The hydrogels created may need further tailoring to be more akin to the 
native bone marrow.  The bone marrow contains other proteins, GAGs, and 
supporting cells not included in this 3D culture system; it is possible that the 
71 
 
incorporation of additional environmental factors may trigger hematopoietic 
differentiation.  The introduction of chemical cues such as growth factors or placing 
the hydrogels in a dynamic or hypoxic environment may also help promote 
hematopoietic differentiation.  The biocompatible HA-PEGDA hydrogel 
differentiation system created in this thesis can be used as a basis for future studies 
incorporating these other factors.   
In conclusion, results presented in this thesis illustrate the complexities of 
ESCs and the difficulties in controlling lineage-specific differentiation.  Advances in 
the regenerative medicine and tissue engineering fields may make ESCs the ideal 
cell source in future years; however, at the present time there are too many 
unknowns associated with ESCs.  Extensive research must continue to be conducted 
in animal models before any significant societal impact can be made using 
embryonic stem cells. 
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